Is 3D Modeling From Non-contrast CT Accurate for Minimally Invasive Lung Segmentectomies ?
NCT ID: NCT07234604
Last Updated: 2025-11-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
50 participants
OBSERVATIONAL
2025-12-01
2026-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Evaluate the impact of 3D reconstruction (from a CT scan without injection of contrast agent) on intraoperative and postoperative results
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Stereotactic Radiosurgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer
NCT00852644
Positron Emission Tomography and Computed Tomography in Planning Treatment for Patients Undergoing 3-Dimensional Conformal Radiation Therapy for Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery. ICORG 06-35
NCT00958321
Functional Imaging of Treatment Effects: A Companion Protocol to a Study of Extracranial Stereotactic Radioablation in Early Stage Non-Small Cell Lung Cancer
NCT00246116
Radiation Therapy Using 3-Dimensional Treatment Planning in Patients With Non-small Cell Lung Cancer
NCT00002484
Functional Lung Avoidance Planning Guided by Lung Perfusion PET/CT Versus Anatomical Planning for Lung Stereotactic Body Radiotherapy
NCT07289646
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Clinical stage IA lung lesions & malignancy
Patient with clinical stage IA lung lesions ≤ 2 cm in diameter AND a suspected or proven malignancy, cf eligibility criteria
Thoraco-abdomino-pelvic CT scan without and with contrast injection.
Eligible patients undergo the usual preoperative procedure, including consultations and CT scan with and without contrast injection.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Thoraco-abdomino-pelvic CT scan without and with contrast injection.
Eligible patients undergo the usual preoperative procedure, including consultations and CT scan with and without contrast injection.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient agreeing to participate in the study
* Patient with clinical stage IA lung lesions ≤ 2 cm in diameter AND a suspected or proven malignancy.
* Chest CT scan available without and then with contrast
* Eligible for VATS or RATS segmentectomy based on respiratory explorations
Exclusion Criteria
* Allergic reactions to radiographic contrast agents
* History of ipsilateral cardiothoracic surgery
* Open segmentectomy (thoracotomy)
* Histology different from that of NSCLC
* Inability to provide the subject with informed information (difficulty understanding the subject, insufficient command of French, etc.)
* Pregnant or breastfeeding women
* Severe cognitive impairment and/or suspicion of lack of compliance or adherence, in the investigator's judgment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service Chirurgie Thoracique - CHU de Strasbourg - France
Strasbourg, Strasbourg, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9776
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.